Customs-Trade Partnership Against Terrorism (C-TPAT) Supply Chain Security and Compliance for Regulated Industries

Overview:

The Customs-Trade Partnership Against Terrorism (C-TPAT) is a voluntary supply chain security program led by U.S. Customs and Border Protection (CBP).  It is intended to improve the security of supply chains of private enterprises against the threat of terrorism.

The program was launched in November 2001, with seven large U.S. companies as the initial participants.  By the end of 2014, more than 10,000 members joined the effort.  More than 4300 importers in the program account for more than half of the value of all merchandise imported into the U.S.

C-TPAT certification can be attained by companies who seek to be considered low risk, enabling their cargo to be processed in an expedited manner with fewer Customs examinations.  The certification involves a documented process for determining and mitigating risk throughout a company’s international supply chain.

The program is voluntary, but affords those participating in it a huge advantage in terms of international trade.  In this webinar, we will explore the best approach to C-TPAT certification and discuss best practices.

Why Should You Attend:

This C-TPAT training will provide valuable assistance to all personnel in FDA-regulated companies currently facing the global challenges of counterfeit and contraband operations, which have a negative impact on their revenue and, potentially, on their reputation.  The industries regulated by FDA that are affected include:

• Supply Chain Management and Analysts
• Quality Assurance Management and Analysts
• Regulatory Affairs Management and Analysts
• Legal Professionals in Manufacturing Companies
• Information Technology Managers and Analysts
• Compliance Managers and Analysts
• Business Stakeholders responsible for manufacturing supply chain functions
• Consultants working in the manufacturing/supply chain sectors of industry
• Transportation personnel who are handling goods and supervisors
• Security personnel responsible for supply chain activities
• Auditors and Inspectors responsible for evaluating supply chain security and compliance
• The webinar should target consultants working in the life sciences industry who are involved in securing their supply chain systems.

The webinar should also be marketed to tobacco and related industry companies, as they are now under FDA regulations (Tobacco Control Act 2009/ Deeming Act 2016) and most have devices that are used to deliver e-liquids.

Areas Covered in this Webinar:

• U.S. Customs and Border Patrol
• C-TPAT Strategy Design
• C-TPAT Certification and Benefits
• International Terrorism as a Challenge
• Mitigation of Terrorist Threats
• Mutual Recognition Arrangements
• Best Industry Practices
• Q&A

Learning Objectives:

• Learn about the role of the U.S. Customs Border Patrol
• Understand the potential threats of international terrorism to a company’s supply chain
• Understand how C-TPAT came to fruition
• Understand the key benefits of C-TPAT certification
• Learn how to comply with requirements for C-TPAT certification
• Learn key ways to mitigate the threats of international terrorism
• Learn how to use technology to combat terrorism while keeping down cost

Who Will Benefit:

Professionals in the following industries may benefit from the content:

• Pharmaceutical
• Medical Devices and Diagnostics
• Biotechnology
• Tobacco and Related (Vapor, e-Cigarette, Cigar, etc.)

Speaker Profile:

Carolyn Troiano has more than 30 years of experience in computer system validation in the pharmaceutical, medical device, animal health, tobacco and other FDA-regulated industries. She is currently an independent consultant, advising companies on computer system validation and large-scale IT system implementation projects.

During her career, Carolyn worked directly, or on a consulting basis, for many of the larger pharmaceutical companies in the US and Europe. She developed validation programs and strategies back in the mid-1980s, when the first FDA guidebook was published on the subject, and collaborated with FDA and other industry representatives on 21 CFR Part 11, the FDA’s electronic record/electronic signature regulation.

Others Details

For more details and updates please visit webinar website